JP2004504032A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004504032A5 JP2004504032A5 JP2002512384A JP2002512384A JP2004504032A5 JP 2004504032 A5 JP2004504032 A5 JP 2004504032A5 JP 2002512384 A JP2002512384 A JP 2002512384A JP 2002512384 A JP2002512384 A JP 2002512384A JP 2004504032 A5 JP2004504032 A5 JP 2004504032A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- pharmaceutical composition
- sep
- activity
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims 18
- 229920001184 polypeptide Polymers 0.000 claims 17
- 230000000694 effects Effects 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 5
- 206010057671 Female sexual dysfunction Diseases 0.000 claims 3
- 201000001880 Sexual dysfunction Diseases 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 231100000872 sexual dysfunction Toxicity 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 102000005593 Endopeptidases Human genes 0.000 claims 2
- 108010059378 Endopeptidases Proteins 0.000 claims 2
- 102000048186 Endothelin-converting enzyme 1 Human genes 0.000 claims 2
- 108030001679 Endothelin-converting enzyme 1 Proteins 0.000 claims 2
- 208000021663 Female sexual arousal disease Diseases 0.000 claims 2
- 206010057672 Male sexual dysfunction Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000002299 complementary DNA Substances 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000003248 secreting effect Effects 0.000 claims 2
- 102000015427 Angiotensins Human genes 0.000 claims 1
- 108010064733 Angiotensins Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 208000010228 Erectile Dysfunction Diseases 0.000 claims 1
- 102000003729 Neprilysin Human genes 0.000 claims 1
- 108090000028 Neprilysin Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 201000001881 impotence Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0017387.2A GB0017387D0 (en) | 2000-07-14 | 2000-07-14 | Novel enzyme |
| PCT/IB2001/001263 WO2002006492A1 (en) | 2000-07-14 | 2001-07-16 | A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004504032A JP2004504032A (ja) | 2004-02-12 |
| JP2004504032A5 true JP2004504032A5 (enExample) | 2005-02-24 |
Family
ID=9895717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002512384A Pending JP2004504032A (ja) | 2000-07-14 | 2001-07-16 | 性的機能不全の処置用の新規なヒト可溶性分泌エンドペプチダーゼ(sep) |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6878529B2 (enExample) |
| EP (1) | EP1303619A1 (enExample) |
| JP (1) | JP2004504032A (enExample) |
| AU (1) | AU2001269371A1 (enExample) |
| CA (1) | CA2415557A1 (enExample) |
| GB (1) | GB0017387D0 (enExample) |
| MX (1) | MXPA03000426A (enExample) |
| WO (1) | WO2002006492A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020086405A1 (en) * | 2000-09-25 | 2002-07-04 | Inmaculada Silos-Santiago | 56638, a novel human neprilysin protease and uses thereof |
| ES2310527T3 (es) * | 1999-11-19 | 2009-01-16 | Solvay Pharmaceuticals B.V. | Enzimas humanas de la familia de las metaloproteasas. |
| US6650943B1 (en) | 2000-04-07 | 2003-11-18 | Advanced Bionics Corporation | Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction |
| GB0017387D0 (en) * | 2000-07-14 | 2000-08-30 | Pfizer Ltd | Novel enzyme |
| US6991916B2 (en) * | 2000-07-14 | 2006-01-31 | Pfizer Inc. | Compounds for the treatment of sexual dysfunction |
| US20020091129A1 (en) * | 2000-11-20 | 2002-07-11 | Mitradev Boolell | Treatment of premature ejaculation |
| US6885895B1 (en) * | 2001-04-26 | 2005-04-26 | Advanced Bionics Corporation | Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction |
| MXPA03010341A (es) * | 2001-05-18 | 2004-03-10 | Solvay Pharm Gmbh | Uso de compuestos con actividad inhibitoria de epn/mp combinada en la preparacion de medicamentos. |
| US7427611B2 (en) | 2003-09-26 | 2008-09-23 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| US7262184B2 (en) | 2003-09-26 | 2007-08-28 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| US7452875B2 (en) | 2003-09-26 | 2008-11-18 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| US20050267072A1 (en) * | 2004-05-14 | 2005-12-01 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction |
| WO2005112940A1 (en) * | 2004-05-14 | 2005-12-01 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and pde v inhibitors |
| US20050267124A1 (en) * | 2004-05-14 | 2005-12-01 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors |
| WO2005112460A2 (en) * | 2004-05-17 | 2005-11-24 | Given Imaging Ltd. | Method, system and device for in-vivo biopsy |
| MX2009010000A (es) | 2007-03-19 | 2010-03-17 | Insuline Medical Ltd | Dispositivo para el suministro de farmaco. |
| US8622991B2 (en) | 2007-03-19 | 2014-01-07 | Insuline Medical Ltd. | Method and device for drug delivery |
| US9220837B2 (en) | 2007-03-19 | 2015-12-29 | Insuline Medical Ltd. | Method and device for drug delivery |
| US8409133B2 (en) | 2007-12-18 | 2013-04-02 | Insuline Medical Ltd. | Drug delivery device with sensor for closed-loop operation |
| CA2743027C (en) | 2008-11-07 | 2016-04-12 | Insuline Medical Ltd. | Device and method for drug delivery |
| ES2627655T3 (es) | 2009-05-19 | 2017-07-31 | Neuroderm Ltd | Composiciones para la administración continua de inhibidores de DOPA descarboxilasa |
| JP5902705B2 (ja) | 2010-11-15 | 2016-04-13 | ニューロダーム リミテッドNeuroderm Ltd | L−ドーパ、ドーパデカルボキシラーゼ阻害剤、カテコール−o−メチルトランスフェラーゼ阻害剤、およびそれらのための組成物の継続的投与 |
| WO2013025261A2 (en) * | 2011-04-06 | 2013-02-21 | Georgia Tech Research Corporation | Fluorogenic peptide probes and assays |
| US9375202B2 (en) | 2012-05-04 | 2016-06-28 | Given Imaging Ltd. | Device and method for in vivo cytology acquisition |
| WO2013183055A1 (en) | 2012-06-05 | 2013-12-12 | Neuroderm Ltd | Compositions comprising apomorphine and organic acids and uses thereof |
| US10258585B2 (en) | 2014-03-13 | 2019-04-16 | Neuroderm, Ltd. | DOPA decarboxylase inhibitor compositions |
| PT3116475T (pt) | 2014-03-13 | 2020-12-15 | Neuroderm Ltd | Composições de inibidores de dopa-descarboxilase |
| CN112546453B (zh) * | 2020-10-15 | 2022-11-29 | 西安蓝极医疗电子科技有限公司 | 基于激光照射治疗男性勃起功能障碍的发光体组件及装置 |
| US11844754B2 (en) | 2020-11-17 | 2023-12-19 | Neuroderm, Ltd. | Methods for treatment of Parkinson's disease |
| US11331293B1 (en) | 2020-11-17 | 2022-05-17 | Neuroderm, Ltd. | Method for treatment of Parkinson's disease |
| US11213502B1 (en) | 2020-11-17 | 2022-01-04 | Neuroderm, Ltd. | Method for treatment of parkinson's disease |
| US12161612B2 (en) | 2023-04-14 | 2024-12-10 | Neuroderm, Ltd. | Methods and compositions for reducing symptoms of Parkinson's disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2777291B1 (fr) * | 1998-04-08 | 2000-07-07 | Inst Nat Sante Rech Med | Nouvelle metalloprotease membranaire nep ii et son utilisation pour le criblage d'inhibiteurs utiles en therapie |
| CA2260376A1 (en) | 1999-02-11 | 2000-08-11 | Universite De Montreal | New metalloproteases of the neprilysin family |
| EP1069188A1 (en) | 1999-07-15 | 2001-01-17 | Sanofi-Synthelabo | Three neprilysin-like membrane metallopeptidases |
| GB0017387D0 (en) * | 2000-07-14 | 2000-08-30 | Pfizer Ltd | Novel enzyme |
-
2000
- 2000-07-14 GB GBGB0017387.2A patent/GB0017387D0/en not_active Ceased
-
2001
- 2001-07-13 US US09/905,846 patent/US6878529B2/en not_active Expired - Fee Related
- 2001-07-16 EP EP01947731A patent/EP1303619A1/en not_active Withdrawn
- 2001-07-16 CA CA002415557A patent/CA2415557A1/en not_active Abandoned
- 2001-07-16 JP JP2002512384A patent/JP2004504032A/ja active Pending
- 2001-07-16 AU AU2001269371A patent/AU2001269371A1/en not_active Abandoned
- 2001-07-16 MX MXPA03000426A patent/MXPA03000426A/es unknown
- 2001-07-16 WO PCT/IB2001/001263 patent/WO2002006492A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004504032A5 (enExample) | ||
| MXPA03000426A (es) | Una endopeptidasa secretada soluble humana novedosa para el tratamiento de disfuncion sexual. | |
| RU2008136324A (ru) | Желудочно-кишечный пролиферативный фактор и его применения | |
| JP2004536077A5 (enExample) | ||
| MX340014B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX342291B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX340016B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MXPA01007956A (es) | Polipeptido antimicrobiano/neutralizador de endotoxina. | |
| JP2012530504A5 (enExample) | ||
| HRP20160798T1 (hr) | Rekombinantni antigeni iz rsv | |
| TW200602071A (en) | Methods for preventing and treating alzheimer's disease (ad) | |
| JP2011528895A5 (enExample) | ||
| WO2004064717A3 (en) | Cop 1 for treatment of inflammatory bowel diseases | |
| WO2000011000A3 (en) | New compounds | |
| JP2002525081A5 (enExample) | ||
| EP2114431A4 (en) | COMPOSITION WITH ARAZYM FOR THE PREVENTION AND TREATMENT OF CANCER | |
| WO2000010999A3 (en) | New compounds | |
| JP2004527452A5 (enExample) | ||
| JP2011507498A5 (enExample) | ||
| NZ541231A (en) | A method of treatment or prophylaxis of symptoms of herpes viral infection | |
| UA83989C2 (ru) | Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение | |
| JP2008531463A5 (enExample) | ||
| WO2007014253A3 (en) | Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure | |
| CA3132808C (en) | NEW PEPTIDE AND ITS USE | |
| WO2003099226A3 (en) | Antibody peg positional isomers, compositions comprising same, and use thereof |